drugset / Trial / NCT00607074

Impact of Anti-Giardia and Antihelmintic Treatment on Infant Growth in Bangladesh

NCT00607074

Completed 410 enrolled University of Cambridge
RandomizedParallel-groupDouble-blindTreatment

Summary

This longitudinal study aimed to assess whether regular anti-Giardia and antihelmintic treatment improved growth and small intestinal mucosal function of rural Bangladeshi infants.

Timeline

Start
2003-06
Primary completion
2004-04
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Albendazole Small molecule 200 mg
Subject Secnidazole Small molecule

Indications